Paul Carbone has been the President and Managing Partner of Pritzker Private Capital and its predecessor, Pritzker Group Private Capital, since 2012. Pritzker Private Capital partners with entrepreneur‐ and family‐owned middle‐market companies with leading positions in the manufactured products, services and healthcare sectors. For the prior 13 years, Paul was the Director and Managing Partner of the Private Equity Group of Robert W. Baird & Co., which makes venture capital, growth equity and buyout investments in smaller, high‐potential companies in the US, Europe and Asia. Prior to 1999, Paul was the Co‐Director of Investment Banking responsible for Robert W. Baird & Co.’s Mergers and Acquisitions Advisory practice. Prior to joining Robert W. Baird & Co. in 1994, Paul was Senior Vice President in the Investment Banking Group at Kidder, Peabody & Co.
Paul is on the board of directors of several civic, cultural and charitable organizations, including the Shedd Aquarium (Executive Committee and Chair of the Finance Committee), University of Chicago Medical Center (Executive Committee and Chair of the Finance Committee) and The Art Institute of Chicago. He also advises the Misericordia Endowment Fund and is a member of the Commercial Club of Chicago and the Economic Club of Chicago.
In 2016, Paul received the Stanley C. Golder Award from the Illinois Venture Capital Association in recognition of his contributions to the private equity industry in Illinois. Paul has served as an EY Entrepreneur of the Year regional judge as well as national judge for the Family Business category. In 2020, Family Capital magazine named Paul one of the Top 100 most influential people among family investors and family enterprises.
Paul is a Phi Beta Kappa graduate of The College of the University of Chicago. He received his MBA from Harvard Business School.
Eric Kieras is a Partner at Pritzker Private Capital and helps lead the firm's Services sector investing. Prior to joining Pritzker Private Capital, Eric was a Managing Director at JZ Partners, LLC, a middle-market investment firm, where he helped lead investment strategy and execution and served on the Boards of Directors of several of the firm's operating companies. Prior to joining JZ Partners, Eric worked as an investment banker for the plastics and packaging team at P&M Corporate Finance, a regional investment bank focused on middle-market M&A transactions.
Eric received his B.B.A. from the University of Michigan Ross School of Business.
Dave is an Operating Partner at Pritzker Private Capital leading the firm’s activities in the Healthcare sector. Prior to joining Pritzker Private Capital, Dave was most recently executive chairman and CEO of LabCorp (NYSE: LH). Dave is a respected senior healthcare leader who operates with a strong emphasis on deeply understanding the healthcare industry, strategic planning, “playing the long game,” and staying ahead of rapidly evolving industry trends and challenges. Under his leadership, LabCorp transformed from a pure-play U.S. testing laboratory into a leading global life sciences company — tripling in size through a combination of organic growth and strategic acquisitions, entering the Fortune 500, and being named to Fortune’s List of World’s Most Admired Companies. It is now the world’s largest clinical laboratory and second-largest drug development business.
Dave is the board chair of PATH, a nonprofit global health organization, and was appointed in 2017 to the advisory board for Duke University’s Robert J. Margolis, MD, Center for Health Policy. He previously served on the board of Cardinal Health (NYSE: CAH), a Fortune 20 healthcare company, Elon University and the American Clinical Laboratory Association, where he served as board chair from 2010 to 2014. Dave is also on the board of The Emily K Center, a college-readiness center that Duke Men's Basketball Coach Mike Krzyzewski founded to prepare high school students in Durham, North Carolina for college and leadership.
Dave holds a bachelor’s degree, cum laude, from Princeton University and a Juris Doctor, cum laude, from the University of Pennsylvania Law School.
Terry is an Operating Partner at Pritzker Private Capital leading the firm’s activities in the Manufactured Products sector. Terry has more than 25 years of executive experience in refining, specialty chemicals, plastics, process automation and steel. Prior to joining Pritzker Private Capital, Terry was an Executive Advisor and member of the Advisory Board of Aurora Capital Partners for ten years. Prior to Aurora, Terry was COO of Gerdau Ameristeel, one of the largest long steel producers in North America. Previously, Terry joined Tyco International as one of the operating executives charged with turning around Tyco, assuming the role of President of Tyco Plastics and Adhesives. Earlier in his career he was part of AlliedSignal, which ultimately became Honeywell, in Specialty Chemicals where he had numerous roles in Business Development, Marketing and was the VP-GM of the global Fluorine Products business and then President of the global Process Solutions Division. Terry began his career with Pennzoil and Morton International.
Terry received his B.S. in Chemical Engineering from University of Missouri-Columbia, a M.S. in Chemical Engineering from Texas A&M University and an M.B.A. from the University of Chicago.
Jeff Carlson joined Pritzker Private Capital in 2020 as the Director of Technology; overseeing the IT team and providing strategic and tactical guidance to Pritzker Private Capital’s companies. Jeff has served as Director of Information Technology at Pritzker Group since 2014. Prior to joining Pritzker Group, Jeff was Vice President of Information Technology at SunTrust Robinson Humphrey, where he developed applications for the firm’s Total Return Swap trading desk and worked in an operations and technology capacity. Before SunTrust, Jeff worked as a Vice President at Bank of America, and began his career at Vista Software Solutions, now part of JDA Software.
Jeff received his Bachelor degree in Business Administration and Masters in Information Systems at Northern Illinois University.
Prior to joining Pritzker Private Capital, Patrick was an investment banking associate in the Services & Industrials Group at William Blair in Chicago. While at William Blair, Patrick provided analytical support on mergers, acquisitions, leveraged buyouts, financings and other financial advisory services.
Patrick received his B.B.A. in finance from the University of Notre Dame.
Prior to joining Pritzker Private Capital, Matthew was an investment banking analyst in the Consumer & Retail Group at RBC Capital Markets in New York. While at RBC, Matthew provided analytical support on financings, mergers, acquisitions, leveraged buyouts and other financial advisory services.
Matthew received his B.S. in Finance from Indiana University.
Noelia joined Pritzker Private Capital in 2020 as an Executive Assistant and supports the Services team. Prior to joining Pritzker Private Capital, Noelia was an Executive Assistant at BDT & Company, LLC where she supported the Network Team. Prior to BDT, Noelia was an Executive Assistant at Wind Point Partners, a private equity investment firm.
Noelia received her B.A. in Psychology and Art from the University of Iowa, with an Honors in Art.
Matt Cook is the former CEO of LBP Manufacturing, a Pritzker Private Capital company. Under his leadership over 20 years, the company expanded manufacturing products and services around the globe. LBP services a broad range of clients with fiber-based and sustainable foodservice packaging. Companies such as McDonalds, Dunkin Donuts and Starbucks seek differentiation, innovation and sustainability in their packaging portfolios.
Ruby Chandy was formerly President of the $1.3B Industrial Division of Pall Corporation. Earlier in her career, Ruby held general management positions at Dow Chemical, Thermo Fisher Scientific, Boston Scientific, and Millipore. She also served as Chief Marketing Officer at Dow Chemical and Thermo Fisher Scientific.
Ruby currently serves on the boards of Ametek, DuPont, and Flowserve Corporations and was previously on the board of Idex Corporation from 2006-2013. Ruby served on the board of Infiltrator Water Technologies, a portfolio company of Ontario Teachers Private Capital and on the Executive Advisory Board of Gryphon Investors, a private equity firm based in San Francisco. She is a Mentor-in-Residence for University of Pennsylvania PCI Ventures.
Ruby is currently on the Americas Executive Board of the MIT Sloan School and was previously on the board of Unicef New England. Ruby received her Bachelor’s degree in Materials Science and Engineering from MIT, a Master’s Degree in Materials Science and Engineering from Northwestern University, and a Master’s degree in Business from the MIT Sloan School
Phillip has served as a board member on several company, educational and civic organizational boards. He is currently serving on the board of Rockwell Automation, a public company providing industrial automation and information technology. He also sits on the board of the University of Cincinnati Board of Trustees and The Urban League of Greater Southwestern Ohio.
Phillip received his Bachelor’s degree in Engineering from the University of Cincinnati.
Alan Muney previously served as Cigna’s Chief Medical Officer and Executive Vice President of Total Health and Network. In his role as Chief Medical Officer, Alan was responsible for Cigna’s clinical strategy and policy, health advocacy programs, coverage policy, and quality measurement and improvement. As lead for Total Health and Network, Alan was responsible for the market medical and clinical nurse executives, total health physician operations, total health clinical operations, dental clinical operations, as well as medical, behavioral and dental contracting. Alan also oversaw Cigna’s team of doctors, dentists, nurses and behavioral health clinicians involved in the company’s health management and wellness programs.
Before joining Cigna, Alan was an Executive Director in the Private Equity Group at The Blackstone Group, and the CEO of Equity Healthcare, which he founded to manage the healthcare costs of Blackstone’s portfolio companies. While at Blackstone, he also served on the Board of Directors of Vanguard Health System and Team Health. Prior to Blackstone, Alan was the executive vice president and chief medical officer of Oxford Health Plans and chief medical officer of United Healthcare of the Northeast region from 1998-2007. Prior to that, he was senior vice president and chief medical officer for Avanti Health systems, a division of NYLCare health plans. He was also regional medical director for Mullikin Medical Centers, a large multi-specialty medical group in California. He is also a frequent lecturer on issues in managed health care.
Board-certified in pediatrics, Alan received his B.S. in Biology and his Doctor of Medicine degrees from Brown University, and a Master in Health Administration from the University of La Verne.
Stephen Newlin is the former Chairman and CEO of Univar Solutions, a global chemical and ingredient distributor. Previously, Steve served as Chairman, President and Chief Executive Officer of PolyOne Corporation from 2006-2014 and Executive Chairman of the Board until 2016. Prior to PolyOne, Steve was President, Industrial Sector, at Ecolab Incorporated. He also spent 24 years at Nalco Chemical Company in positions of increasing responsibility, ultimately serving as President and Director of Nalco, and then President, Chief Operating Officer, and Vice Chairman.
Steve has served as a board member or director for many public companies, associations and civic organizations. Currently, he serves on the board of Univar Solutions and Hexion. He also currently serves as Chairman of the Oshkosh Corporation, a leading innovator of mission-critical vehicles and equipment.
Steve received a Bachelor’s degree in civil/environmental engineering and an honorary doctorate of public service from the South Dakota School of Mines & Technology. He completed the Tuck Executive Program at Dartmouth College, as well as Harvard Business School's Advanced Management Program. He also served as a commissioned officer in the U.S. Public Health Service, earning an accelerated promotion.
Doug Oberhelman served as Chairman of the Board of Directors and as Chief Executive Officer of Caterpillar Inc. beginning in 2010. After a 41-year career with Caterpillar, he retired as CEO in December 2016 and as Executive Chairman in March 2017.
Doug joined the Caterpillar treasury department in 1975 and worked in or led a wide variety of businesses across the company. He was elected a Caterpillar Vice President and Chief Financial Officer in 1995; and from 2002 to 2010 was a group President with responsibility for many of Caterpillar’s core businesses. Over the course of his career at Caterpillar he lived in North America, South America and Asia, and travelled extensively throughout the world.
Doug serves on the Board of Directors of Exxon Mobil Corporation, Peter Kiewit Sons’, Inc., and Bombardier Inc. He is former Chair of both the Business Roundtable and the National Association of Manufacturers. He serves as vice president of the Wetlands America Trust, is a director on the boards of the Max McGraw Wildlife Foundation and Intersect Illinois. He is also Chairman of the Board of Trustees for the Easter Seals Foundation of Central Illinois. He previously served on the boards of Eli Lilly and Company and Ameren Corporation.
David Steiner is a member of the Board of Directors of FedEx, where he serves as Lead Director, and Vulcan Materials, where he serves as the Chairperson of the Nominating and Governance Committee. From 2004 until November 2016, David served as CEO and President of Waste Management, the largest solid waste and recycling company in North America. He also held the positions of CFO, General Counsel and Corporate Secretary, and Deputy General Counsel.
Mr. Steiner serves on a number of non-profit and educational boards, including the EJ Ourso School of Business at LSU. David graduated from the UCLA School of Law, with honors, and practiced Corporate and Securities law at Phelps Dunbar, Gibson, Dunn and Crutcher and Jones Walker. David also has a Bachelor of Science in Accounting from Louisiana State University, where he graduated cum laude.
Mike Lynch is a Senior Advisor to Pritzker Private Capital, counseling the firm’s Healthcare companies. Prior to his Senior Advisor role, Mike was an Operating Partner, leading the firm’s operating activities in the Healthcare sector. Mike previously served as chief executive officer of Cardinal Health’s medical segment, a multi-billion dollar business with more than 15,000 employees in nine countries serving hospitals, clinics and other sites of care worldwide. Mike is a seasoned global executive with 28 years of strategic and operational experience in medical products manufacturing, sourcing and distribution. He held leadership roles in several Cardinal Health businesses, consistently growing them through acquisitions, alliances, organic revenue and operational improvements.
Mike is a graduate of Cornell University and sits on the board of directors for Boston Centerless and AdvaMed. Mike also serves as Chairman of the board of directors of PathGroup, a member of the PPC group of operating companies.
Alan Muney previously served as Cigna’s Chief Medical Officer and Executive Vice President of Total Health and Network. In his role as Chief Medical Officer, Alan was responsible for Cigna’s clinical strategy and policy, health advocacy programs, coverage policy, and quality measurement and improvement. As lead for Total Health and Network, Alan was responsible for the market medical and clinical nurse executives, total health physician operations, total health clinical operations, dental clinical operations, as well as medical, behavioral and dental contracting. Alan also oversaw Cigna’s team of doctors, dentists, nurses and behavioral health clinicians involved in the company’s health management and wellness programs.
Before joining Cigna, Alan was an Executive Director in the Private Equity Group at The Blackstone Group, and the CEO of Equity Healthcare, which he founded to manage the healthcare costs of Blackstone’s portfolio companies. While at Blackstone, he also served on the Board of Directors of Vanguard Health System and Team Health. Prior to Blackstone, Alan was the executive vice president and chief medical officer of Oxford Health Plans and chief medical officer of United Healthcare of the Northeast region from 1998-2007. Prior to that, he was senior vice president and chief medical officer for Avanti Health systems, a division of NYLCare health plans. He was also regional medical director for Mullikin Medical Centers, a large multi-specialty medical group in California. He is also a frequent lecturer on issues in managed health care.
Board-certified in pediatrics, Alan received his B.S. in Biology and his Doctor of Medicine degrees from Brown University, and a Master in Health Administration from the University of La Verne.